German CRO opens U.K. subsidiary

Thursday, May 26, 2011 02:37 PM

Accovion, a European CRO based in Eschborn, Germany, has extended its reach into what it terms a “key strategic territory” with a new subsidiary, Accovion Ltd., in Windsor, U.K., according to PharmaTimes.

Not only has the U.K. always been a key strategic territory for the company, but also Accovion’s expanding regulatory portfolio and growing involvement in device pharmacovigilance and health economics meant it was “imperative for us to be firmly implanted in London,” said chief operating officer Ivana Waller. 

The company was already established at two locations in Germany as well as in the Czech Republic, Poland, Romania and Russia. The Czech and Russian subsidiaries opened last December.

The U.K. subsidiary, which will be headed up by newly appointed managing director Carl Naraynassamy, “consolidates our presence in Europe and affords us a sure platform to access the considerable local clinical research talent and respond even better to our clients' growing needs,” said Waller.

Accovion’s strategic plan for 2011 includes formalizing activities in a number of other European countries by setting up additional subsidiaries.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 21

As job growth in drug development sector soars, more employees are seeking new opportunities

U.K. study: Prisoners should have the right to participatein clinical trials on moral grounds, for healthcare access

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs